Stockreport

ProSomnus® Receives FDA Class II Clearance for RPMO2 OSA Device

Lakeshore Acquisition I Corp. - Ordinary Shares  (LAAA) 
PDF SAN FRANCISCO, April 13, 2026 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (“the Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer [Read more]